BioNTech Stock Rises After Reiterating Guidance

BNTX is still down over 40% year-to-date

Deputy Editor
May 9, 2022 at 9:33 AM
facebook twitter linkedin


The shares of BioNTech SE (NASDAQ:BNTX) are inching higher ahead of the open, last seen up 0.8% at $137.20, after the pharma giant reported better-than-expected first-quarter earnings, as well as a revenue beat. The company said its quarterly revenues tripled during the quarter, thanks to strong Covid-19 vaccine sales, and stood by its 2022 vaccine revenue guidance.

BioNTech stock took a step back heading into 2022. It's battled the $180 level multiple times over the course of the year, with the 80-day moving average thwarting BNTX's most recent attempt to hold above the area. Fresh off of its third-straight weekly loss, the equity still has a lot of ground to cover if it wants to overcome its 41.3% year-to-date deficit.

Despite the negative price action of late, options traders have favored bullish bets. This is according to BioNTech stock's 50-day call/put volume ratio at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) of 1.72, which stands in the 80th percentile of its annual range. This indicates long calls are being picked up at a faster-than-usual clip. 

It's worth pointing out that BTNX ranks high on the Schaeffer's Volatility Scorecard (SVS), with a score of just 99 out of 100, meaning the security has consistently realized bigger returns than its options implied volatility (IV) levels have priced in. In other words, it could be a strong candidate for premium-buying strategies moving forward. 

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Best stocks for October and worst stocks for October
 


 


 
Special Offers from Schaeffer's Trading Partners